Skip to content
10-Q

Quarterly Report

ACTUATE THERAPEUTICS, INC. ACTU

0001683168-26-003909

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 13, 2026 23.93M sh
Shares Diluted Q1 2026 · Mar 31, 2026 23.54M sh
Shares Diluted Q1 2026 · Mar 31, 2025 19.5M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$5.02M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$4.62M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $8.13M
Stockholders Equity Q1 2026 · Mar 31, 2026 $3.78M
Stockholders Equity Q1 2026 · Dec 31, 2025 $7.92M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$5.09M
Stockholders Equity Q1 2026 · Dec 31, 2024 $104.19K
Current Liabilities Q1 2026 · Mar 31, 2026 $4.72M
Current Liabilities Q1 2026 · Dec 31, 2025 $5.71M
Total Liabilities Q1 2026 · Mar 31, 2026 $5.13M
Total Liabilities Q1 2026 · Dec 31, 2025 $6.11M
Current Assets Q1 2026 · Mar 31, 2026 $8.52M
Current Assets Q1 2026 · Dec 31, 2025 $13.64M
Total Assets Q1 2026 · Mar 31, 2026 $8.91M
Total Assets Q1 2026 · Dec 31, 2025 $14.04M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.24
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.32
Eps Basic Q1 2026 · Mar 31, 2026 −$0.24
Eps Basic Q1 2026 · Mar 31, 2025 −$0.32
Sga Expense Q1 2026 · Mar 31, 2026 $3.14M
Sga Expense Q1 2026 · Mar 31, 2025 $3.15M
Rd Expense Q1 2026 · Mar 31, 2026 $2.57M
Rd Expense Q1 2026 · Mar 31, 2025 $3.22M
Net Income Q1 2026 · Mar 31, 2026 −$5.63M
Net Income Q1 2026 · Mar 31, 2025 −$6.32M
Operating Income Q1 2026 · Mar 31, 2026 −$5.71M
Operating Income Q1 2026 · Mar 31, 2025 −$6.37M